Clinical Trial Update: Open Label Study to Assess Safety & Efficacy of QD for Induction of Remission in Pediatric Patients with UC [NA]

View source ↗

Summary

Open-label pediatric trial evaluating the safety and efficacy of QD for induction of remission in Ulcerative Colitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Inflammatory Bowel Disease
• Ulcerative Colitis

Drugs mentioned

• QD

Snippet

Sponsor: Shaare Zedek Medical Center | Conditions: Ulcerative Colitis, Inflammatory Bowel Diseases | NA | Status: COMPLETED